股票 › GDRX
好药价 GDRX
美股市值排名 #3098
$3.51 +$0.02 (+0.57%)
休市 · Nov 7, 5:10 am ET · 最新盘后价 $3.54 +0.85%
开盘$3.43
昨收$3.49
当日区间$3.33 – $3.55
成交量1.17M
市值$1.20B
市盈率（TTM）58.5
股息率–
GDRX 相关新闻
匹配 GoodRx 或代码 GDRX 的头条新闻，按最新排序。
- BofA Securities Maintains GoodRx(GDRX.US) With Sell Rating, Maintains Target Price $2.65
- Goldman Sachs Maintains GoodRx(GDRX.US) With Hold Rating, Raises Target Price to $4 正面
- Morgan Stanley Maintains GoodRx(GDRX.US) With Hold Rating, Raises Target Price to $4 正面
- Raymond James Maintains GoodRx(GDRX.US) With Buy Rating, Announces Target Price $4.5
- A Quick Look at Today's Ratings for GoodRx(GDRX.US), With a Forecast Between $4 to $5
- Analysts' Opinions Are Mixed on These Healthcare Stocks: GoodRx Holdings (GDRX), Xencor (XNCR) and PepGen Inc. (PEPG)
- GoodRx(GDRX.US) 10% Shareholder Sells US$5.48 Million in Common Stock
- BofA Securities Maintains GoodRx(GDRX.US) With Sell Rating, Raises Target Price to $2.65 正面
- GoodRx(GDRX.US) 10% Shareholder Sells US$4.2 Million in Common Stock
- Truist Financial Maintains GoodRx(GDRX.US) With Hold Rating
- TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $5
- UBS Maintains GoodRx(GDRX.US) With Hold Rating, Raises Target Price to $3.75 正面
- TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Raises Target Price to $5 正面
- Citi Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $5
- Citi Maintains GoodRx(GDRX.US) With Buy Rating, Raises Target Price to $5 正面
暂无评论——快来第一个聊聊 GDRX。
登录后参与讨论。